[ad_1]
WASHINGTON: In a major development, the US Food and Drug Administration. USA He approved the first Covid-19 home test kit, which is expected to bring coronavirus testing to the doorstep of every home.
The first home test kit was developed by LabCorp, an American company that has a network of medical laboratories across the country. It costs $ 119 in the United States.
“This is a test where, under certain circumstances, with the supervision of the doctor, a test can be mailed to a patient, and the patient can do the swab and then mail it in and get the results after that time all under the guidance of a medical graduate, ”FDA Commissioner Stephen M Hahn told reporters at a White House press conference.
Earlier this week, Adam Schechter, LabCorp President and CEO, said his home collection kits are designed to make it easier and safer to evaluate healthcare workers and the first responders during this important time. .
The authorization allows nasal swab samples to be collected at home using the home test collection kit if recommended by a healthcare provider after completing a Covid-19 questionnaire, LabCorp said.
[ad_2]
The first home test kit was developed by LabCorp, an American company that has a network of medical laboratories across the country. It costs $ 119 in the United States.
“This is a test where, under certain circumstances, with the supervision of the doctor, a test can be mailed to a patient, and the patient can do the swab and then mail it in and get the results after that time all under the guidance of a medical graduate, ”FDA Commissioner Stephen M Hahn told reporters at a White House press conference.
Earlier this week, Adam Schechter, LabCorp President and CEO, said his home collection kits are designed to make it easier and safer to evaluate healthcare workers and the first responders during this important time. .
The authorization allows nasal swab samples to be collected at home using the home test collection kit if recommended by a healthcare provider after completing a Covid-19 questionnaire, LabCorp said.
